Appendix 4C for Q2 2017
July 31, 2017
In accord with ASX requirements, Imagion Biosystems’ quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July, 2017, accompanied by
Tag: IPO
Imagion Biosystems Identifies Key Operational Objectives
July 12, 2017
Imagion Biosystems Limited (Imagion, ASX:IBX), is pleased to provide shareholders and interested parties an outline of its operational objectives as it moves toward first-in-human testing
Imagion Biosystems Raises A$12 million in Initial Public Offering
June 21, 2017
Imagion Biosystems is now a publicly traded company after completing a heavily supported A$12 million initial public offering (IPO) on the Australian Securities Exchange. Imagion